Benitec Biopharma (ASX:BLT) has created a novel combination of gene therapy and RNA interference (gene silencing) to change treatment paradigms of human disease.
Why invest in Benitec?
See why investors are investing in Benitec's platform, strategy, pipeline and IP strength.
Can't find what you're looking for? Try our FAQ.
Access Benitec's Corporate Directory here.